Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Oliver Schubert

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Brain, Behavior, and Immunity|June 12, 2020
Exploratory study of association between blood immune markers and cognitive symptom severity in major depressive disorder: Stratification by body mass index statusCélia Fourrier, Emma Sampson, Hikaru Hori, et al.
The International Journal of Neuropsychopharmacology|March 5, 2024
Emotional Blunting in Depression in the PREDDICT Clinical Trial: Inflammation-Stratified Augmentation of Vortioxetine With CelecoxibEmma Sampson, Erhan Kavakbasi, Natalie T Mills, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 12, 2017
Impact of a history of maternal depression and anxiety on asthma control during pregnancyLuke E Grzeskowiak, Brian Smith, Anil Roy, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 10, 2021
No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trialBernhard T Baune, Emma Sampson, Jennie Louise, et al.
The Australian and New Zealand Journal of Psychiatry|March 22, 2021
Demonstration of automated non-adherence and service disengagement risk monitoring with active follow-up for severe mental illnessNiranjan Bidargaddi, Geoffrey Schrader, Hannah Myles, et al.
BMC Women'S Health|November 20, 2022
A prospective registry analysis of psychosocial and metabolic health between women with and without metabolic syndrome after a complicated pregnancyEmily Aldridge, K Oliver Schubert, Maleesa Pathirana, et al.
Brain, Behavior, and Immunity|September 7, 2024
Long-term characterisation of the relationship between change in depression severity and change in inflammatory markers following inflammation-stratified treatment with vortioxetine augmented with celecoxib or placeboEmma Sampson, Natalie T Mills, Hikaru Hori, et al.
Plos One|July 26, 2017
Trajectories of anxiety and health related quality of life during pregnancyK Oliver Schubert, Tracy Air, Scott R Clark, et al.
Journal of Neurochemistry|August 28, 2023
Inflammation-stratified augmentation of vortioxetine with celecoxib: Results from a double-blind, randomized, placebo-controlled trial in major depressive disorderErhan Kavakbasi, Emma Sampson, Natalie T Mills, et al.
Translational Psychiatry|September 14, 2021
Autoantibody profiles associated with clinical features in psychotic disordersAugust Jernbom Falk, Cherrie Galletly, David Just, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Brain, Behavior, and Immunity|June 12, 2020
Exploratory study of association between blood immune markers and cognitive symptom severity in major depressive disorder: Stratification by body mass index statusCélia Fourrier, Emma Sampson, Hikaru Hori, et al.
The International Journal of Neuropsychopharmacology|March 5, 2024
Emotional Blunting in Depression in the PREDDICT Clinical Trial: Inflammation-Stratified Augmentation of Vortioxetine With CelecoxibEmma Sampson, Erhan Kavakbasi, Natalie T Mills, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 12, 2017
Impact of a history of maternal depression and anxiety on asthma control during pregnancyLuke E Grzeskowiak, Brian Smith, Anil Roy, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 10, 2021
No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trialBernhard T Baune, Emma Sampson, Jennie Louise, et al.
The Australian and New Zealand Journal of Psychiatry|March 22, 2021
Demonstration of automated non-adherence and service disengagement risk monitoring with active follow-up for severe mental illnessNiranjan Bidargaddi, Geoffrey Schrader, Hannah Myles, et al.
BMC Women'S Health|November 20, 2022
A prospective registry analysis of psychosocial and metabolic health between women with and without metabolic syndrome after a complicated pregnancyEmily Aldridge, K Oliver Schubert, Maleesa Pathirana, et al.
Brain, Behavior, and Immunity|September 7, 2024
Long-term characterisation of the relationship between change in depression severity and change in inflammatory markers following inflammation-stratified treatment with vortioxetine augmented with celecoxib or placeboEmma Sampson, Natalie T Mills, Hikaru Hori, et al.
Plos One|July 26, 2017
Trajectories of anxiety and health related quality of life during pregnancyK Oliver Schubert, Tracy Air, Scott R Clark, et al.
Journal of Neurochemistry|August 28, 2023
Inflammation-stratified augmentation of vortioxetine with celecoxib: Results from a double-blind, randomized, placebo-controlled trial in major depressive disorderErhan Kavakbasi, Emma Sampson, Natalie T Mills, et al.
Translational Psychiatry|September 14, 2021
Autoantibody profiles associated with clinical features in psychotic disordersAugust Jernbom Falk, Cherrie Galletly, David Just, et al.
Pageof 4